China-linked groups using stealthy malware to hack software suppliers, steal national-security and trade data Cybersecurity Dive

FDA approves breast cancer drug
The FDA has approved Eli Lilly’s imlunestrant, an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor positive, HER2-negative, ESR1-mutated advanced or